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Abstract
Nano preparation of drug to be helpful in targeted delivery, which avoids any unwanted damage of adjacent healthy tissues.
Antidiabetic compounds from natural and synthetic sources have been found to successful management of diabetes. Antioxidants
are compound that protect cell against the damaging effects of reactive oxygen species (ROS). Curcumin has many beneficial
effects against health problems; it has limited use due to its poor bioavailability as concluded by number of its pharmacokinetic
studies. Since the aim of this study was to investigate the effectsof curcumin nanoparticles (Nano-curcumin) on antioxidative
enzymes i.e Glutathione peroxidase (GPx), Superoxide dismutase (SOD) and Catalase (CAT) in pancreas of diabetic mice. For
the present investigation mice (Mus musculus) used as experimental animal.Mice were divided into four groups viz, a) Control
group b) Diabetic group c) Recovery group I- Diabetic mice treated with curcumin d) Recovery group II - Diabetic mice treated with
curcumin and nano-curcumin. The activity of antioxidative enzymes in the pancreas was recorded at the end of experiment. There
was decrease in antioxidative enzymes in pancreas of diabetic mice compared to control. After the treatment of curcumin and
curcumin nanoparticles significant increase in levels of antioxidative enzymes in recovery group I and II was observed. Moreover
as compare to free curcumin nano-curcumin showed better results in enhancement of antioxidative enzymes. Thus it proves that
nano-curcumin found to be potent antioxidative compound to reduced oxidative stress induced during the diabetes.
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Introduction
Nanotechnology is the advance branch of science which has
been implemented in agriculture, food and medical science and
its related products. Nano preparation of drug to be helpful in
targeted delivery which avoids any unwanted damage of adja-
cent healthy tissues. [1-3]. Various studies showed that nanopar-
ticles are smoothly enters through cell membranes in organisms
and get interacted quickly with biological systems because of its
number of advantages such as targeted drug delivery, bioavail-
ability, less immunogenicity and also overcomes traditional ther-
apy problems like less bioavailability and adverse effects [4,5].
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Diabetes mellitus (DM) is a disorder having critical priority
because of its worldwide appearance by the International Dia-
betes Institute (IDI) [6]. It is estimated that about 300 million
(5.4%) adult population worldwide have this disease by the year
2025 [7]. Diabetes is ranked third after cancer, cerebrocardio-
vascular diseases in the list of epidemic diseases. Diabetes also
known one of the economic disorder because it puts severe fi-
nancial burden on the victim and their family concerns.
Oxidative damage to DNA, proteins and lipids can ultimately
lead to outcomes such as disorganization, dysfunction and de-
struction of membranes, enzymes and proteins. Specifically, per-
oxidation of membrane lipids may cause impairment of mem-
brane function, decreased fluidity, inactivation of membrane
bound receptors and enzymes, increased permeability to ions
and possibly eventually membrane rupture. The oxidative stress
is particularly severe it can produce cell death.
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In the diabetic state increased oxidative stress results in rapid
damage of islets as compare in other cells [8-10] it is due to
the low expression of antioxidant enzymes such as SOD, CAT
and GPx as compared with other tissues [11], it means that
particularly the β-cells are susceptible to or weakly protected
against oxidative stress. Hyperglycemia increases glucose load
in diabetic case results in efficient production of reactive oxy-
gen species indicating hyperglycemia is a major cause of ROS
generation [12, 13] and protein glycation [14] which causes in-
crease in oxidative stress leads to development of diabetic re-
lated complications [15-18]. Lipid peroxidation results in for-
mation of Malondialdehyde [MDA], which is a secondary prod-
uct of this process and MDA is known to cause cross-linkage of
membrane entities containing amino group’s results in the mem-
brane fragile [19].
Alloxan is responsible for necrosis of beta cells of pancreas
and induces free radicals production which leads to pathogenesis
of both experimental and human diabetes mellitus [20]. Various
scientists reported that H2O2 and free radicals like O2 and OH
produced due to alloxan which are responsible for cellular dam-
age and death. Hence, alloxan was considered sufficient for the
study of pathology of DM [21]. Alloxan easily and rapidly accu-
mulates in pancreatic beta-cell [22] and accumulated alloxan is
responsible for abnormal change in membrane potential and ion
channels in pancreatic beta-cells [23].
Antioxidant play a crucial job in the scavenging the free rad-
ical, neutralizes ROS and defend against oxidative stress in hu-
man body [9]. Superoxide dismutase (SOD), Catalase (CAT) and
Glutathion peroxidase (GPx) are endogenous antioxidant en-
zymes which are responsible for neutralization of harmful oxy-
gen radicals [24].
It has been reported that many herbs and plants possess hypo-
glycemic activity when taken orally [25]. Many medicinal plants
shows antidiabetic prospective or bioactive compounds such as
glycosides, alkaloids, terpenoids, carotenoids and flavonoids are
confirmed to be effective in both preclinical and clinical studies
[26, 27]. Curcumin is component of turmeric which is responsi-
ble for yellow coloration of turmeric [28]. It is an active compo-
nent of the perennial herb Curcuma longa. Curcumin is a popu-
lar spice in Asian cuisine whose beneficial effects on glycemic
control have been used in ayurvedic [29]. Therefore this study
was carried out to evaluate antidiabetic potential of curcumin
nanoparticles on alloxan induced diabetic mice.
Materials and Methods
Chemicals used
Alloxan was purchased from Sigma-Aldrich Company (India).
All experimental chemicals were used of analytical grade and
purchased from Sigma-Aldrich (India).
Preparation of Curcumin nanoparticles
Curcumin nanoparticles were synthesized by drug encapsulation
method described by Jaiswal et al. (2004) [30].
Experimental animal
In present research work, healthy Swiss albino male mice (Mus
Musculus) of 3-4 months age and weighing about 35-45 gm
were used. Mice were maintained in departmental animal
house (1825/PO/EReBi/S/15/CPCSEA) under standard labo-
ratory conditions 12:12 hr L: D cycle light, 21±2ºC temperature
and 55±5% relative humidity. Mice were fed by standard rodent
pelleted diet Nutrinix std-1020 (Nutrivet Life Sciences, Pune)
and water ad libitum. Prior to study all approvals related to ani-
mal study were taken by Committee for the Purpose of Control
and Supervision of Experiments on Animals (CPCSEA), India.
All these animals were maintained and treated as per guidelines
set by the Institutional Animal Ethical Committee (IAEC).
Experimental design 24 male mice were used in present in-
vestigation. Mice were divided into four groups and 6 animals
kept in each.
Control group: Mice were fed standard diet throughout the
experiment and injected with 0.5 ml citrate buffer intraperi-
toneally (IP), pH 4.5.
Diabetic group: Mice were injected with single dose of Al-
loxan (150mg/kg body weight) intraperitoneally (IP); in citrate
buffer; pH 4.5
Recovery group I (Alloxan + Curcumin group): Diabetic
mice were given curcumin (150mg/kg body weight, dissolved in
0.5ml citrate buffer, pH 4.5) intraperitoneally for 20 days.
Recover group II (Alloxan + Curcumin nanoparticles):
Diabetic mice were given curcumin nanoparticles (150mg/kg
body weight, dissolved in 0.5ml citrate buffer, pH 4.5) intraperi-
toneally for 20 days.
After 20 days of treatment, the mice were kept in fasting con-
dition for overnight. Blood glucose was measured using glu-
cometer (Accucheck). After which the mice were sacrificed
by cervical dislocation. Pancreatic tissue were dissected out,
weighted and used for biochemical analysis.
Biochemical analysis
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i. Superoxide Dismutase (SOD) Assay Superoxide dismu-
tase assay was carried out according to method Beauchamp and
Fridovich (1971) [31]. The substrate NBT reduced to blue colour
formazone dye by superoxide radical. The amount of colour
formed was measured at 560 nm on UV-spectrophotometer (Shi-
madzu). One Unit (U) of SOD is defined as the amount of en-
zyme required to inhibit NBT by 50%. The calculated SOD ac-
tivity was expressed as Unit SOD/mg protein.
ii. Catalase (CAT) Assay Catalase assay was carried out
by Luck method (1974) [32]. The enzyme source (0.05ml) was
added to the reaction mixture containing 3ml phosphate buffer
(pH 7.0), hydrogen peroxide (H2O2) and the enzyme activity
was measured at 240nm on UV-spectrophotometer (Shimadzu).
The activity of the enzyme is expressed in unit enzyme/mg pro-
tein.
iii. Glutathione peroxidase (GPx) assay GPx assay was
carried out by Beers and Sizer method (1952) [33]. All the pro-
cedure was same as that of estimation of Catalase. The reaction
mixture contained 3 ml of phosphate buffer with H2O2 and 0.05
ml enzyme source, 0.01 ml of sodium azide (1mM) was added
to inhibit Catalase activity. The absorbance was measured on
UV-spectrophotometer (Shimadzu) at 240 nm. Activity of GPx
expressed in unit/mg protein.
iv. Lipid peroxidation assay Lipid peroxidation level was
determined by Thiobarbituric Acid (TBA) reaction according to
Wills (1966) method [34]. Tissue homogenate (2mg/ml) were
prepared in chilled mortar and pestle using 75mM potassium
phosphate buffer pH 7.0. Malondialdehyde (MDA) is the end
product of fatty acid peroxidation, reacts with TBA gives pink
colored complex which has maximum absorbance at 532 nm.
The concentration of MDA was expressed as nmol MDA/mg wet
tissue.
Statistical Analysis Statistical analysis was done by one-way
ANOVA, Turkey’s HSD test and all values were expressed as
mean ±SD.
Results
The effect of curcumin nanoparticles on pancreatic tissue an-
tioxidant was studied. In table 1, Significant decreased activity
of SOD, CAT and GPx were observed in pancreas of diabetic
mice as compare to control group mice (1:2, P<0.01). Whereas
after treatment of curcumin nanoparticles for 20 days the antiox-
idants were increased significantly by reducing oxidative stress
in recovery group II as compared to diabetic group (2:3, P<0.01).
This increase was twofold as compare to diabetic group mice.
Also curcumin nanoparticles shows good efficiency in oxidative
stress as compare to only curcumin treated mice i.e. recovery I
group (3:4, P<0.01).
In table 2, Blood glucose level of diabetic groups is signifi-
cantly increased due to oxidative stress of alloxan as compare to
control (1:2, P<0.01). While after curcumin nanoparticle treat-
ment for 20 days the blood glucose level was significantly de-
creased in recovery group II as compared to diabetic group (2:3,
P<0.01). Along with this lipid peroxidation was also found to
be significantly raised in diabetic group as compare to control
group (1:2, P<0.01). Whereas after curcumin nanoparticles treat-
ment for 20 days the significant decreased in lipid peroxidation
was observed in recovery group II as compared to diabetic group
(2:3, P<0.01). This decrease was also significant as compare to
curcumin treated mice i.e. recover group I (3:4, P<0.01).
Discussion
Reactive oxygen species (ROS) causes oxidative stress results
in damage to pancreatic and liver cells subsequently leads to di-
abetes mellitus [35, 36] and [37]. Many traditional plants have
been reported that these are effective agents with hypoglycaemic
and antioxidative properties in diabetic mice. In present research
we had synthesize curcumin nanoparticles for the treatment of
diabetes due to poor bioavailability and slow effects of curcumin
shown by various workers. The poor solubility, instability in
physiological fluids, and low bioavailability of curcumin are the
major obstacles for achieving its good results [38]. Therefore,
the present investigation was carried out to find out the antidia-
betic and antioxidative outcomes of curcumin nanoparticles for
treatment of diabetes.
Lenzen et al., 2008 reported that decrease in insulin secretion
as well as glucose uptake by body cells leads to rise in blood glu-
cose, cholesterol and triglycerides and protein contain was de-
crease results from because of alloxan induced beta cell destruc-
tion [37]. Increased blood glucose level responsible for genera-
tion of reactive oxygen species, which cause lipid peroxidation
and membrane damage, also increases oxidative stress in many
organs, especially in the pancreas and liver [39]. In our study,
curcumin nanoparticles treatment at a dose 150 mg/kg body
weight/day for 20 days significantly decreases fasting blood glu-
cose level in recovery group II compared to diabetes group. This
clearly shows that there may be fortification of β cells from ox-
idative damage and stimulation for increase in insulin secretions.
Presence of endogenous antioxidative system like SOD, CAT
and GPx and non-endogenous system such as vitamins E and
C in DM can protect and eradicates ROS and boost antioxida-
tive response in body[40][41]. ROS has been known to produce
cellular and tissue injury through covalent binding, DNA strand
breaking, lipid peroxidation (LPO) and augment fibrosis. In the
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Table 1 Effect of Curcumin nanoparticles onactivity of superoxide dismutase (SOD), Catalase (CAT) and Glutathioneperoxidase (GPx) (Enzyme
























3. Recovery I 35.4200±
1.810
2:3, P<0.01 0.9479± 0.0537 2:3, P<0.01 2.0733±
0.0737
2:3, P<0.01
4. Recovery II 43.9618±
1.477
3:4, P<0.01 1.0545± 0.0529 3:4 P<0.01 2.3284±
0.0316
3:4, P<0.01
P<0.01=Significant, P>0.5= Non significant
Table 2 Effect of curcumin nanoparticles on bloodglucose, Lipid peroxidation in Pancreas of alloxan induced diabeticmice. Values are mean ±S.D
(Numbers inparenthesis denotes number of animals).
Sr. No Group (n=6) Blood glucose (mg/dl) Statistical Significance Lipid Peroxidation in Pancreas Statistical Significance
1. Control 99.4 ± 5.5045 1:2, P<0.01 28.6624 ± 4.0534 1:2, P<0.01
2. Diabetic 370.8 ± 59.5164 1:4, non significant 53.5923 ± 6.5360 1:4 non significant
3. Recovery I 130.2 ± 6.3797 2:3, P<0.01 40.7808 ± 4.3088 2:3, P<0.01
4. Recovery II 103.4 ± 6.3482 3:4, P<0.01 33.2483 ± 4.7961 3:4, P<0.01
P<0.01=Significant, P>0.5= Non significant
present investigation level of MDA was increased and activities
antioxidative enzymes i.e. SOD, CAT and GPx was decreased in
pancreas of diabetic mice similar results suggested by Daunde
et al., 2018 in Trigonelline nanoparticles treatment in HFD-STZ
induced diabetic mice [42]. This results from may be due to
the production of ROS that can responsible for dysfunctioning
of these enzymes and decreased enzymatic antioxidant levels in
the pancreas of mice. Administration of curcumin nanoparticles
to diabetic group significantly decreased the levels of lipid per-
oxidation and increased the activity of SOD, CAT and GPx by
safeguarding pancreas from ROS. This showed that free radical
decreasing ability of curcumin nanoparticles could put forth an
advantageous action against oxidative stress.
Alkaloid and flavonoids are known potential antioxidant in
the treatment of alloxan induced oxidative stress diabetic [43].
Curcumin is a polyphenolic compound reduces glycemia and
hyperlipidemia as well as due to its anti-inflammatory and an-
tioxidant properties it has beneficial effects on diabetic compli-
cations [44]. It is possible that the reduction in alloxan induced
oxidative stress in pancreas of recovery group II is chiefly due
to its antioxidant activity of curcumin nanoparticles. Curcumin
nanoparticles may act by scavenging ROS metabolites due to the
presence of antioxidative property or by increasing the level of
endogenous antioxidant enzymes.
Conclusion
The present investigation suggests that the curcumin nanoparti-
cles enhance body antioxidant activity and develop antioxidant
status, which may have hypoglycemic properties with protec-
tive effect on pancreatic tissues against oxidative stress. More-
over based on the outcome of biochemical analysis curcumin
nanoparticles supposed to be considered as the best medication
on diabetes.
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